These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8054477)

  • 1. Positive and negative regulation of IL-2 gene expression: role of multiple regulatory sites.
    Zhang L; Nabel GJ
    Cytokine; 1994 May; 6(3):221-8. PubMed ID: 8054477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interleukin-8 AP-1 and kappa B-like sites are genetic end targets of FK506-sensitive pathway accompanied by calcium mobilization.
    Okamoto S; Mukaida N; Yasumoto K; Rice N; Ishikawa Y; Horiguchi H; Murakami S; Matsushima K
    J Biol Chem; 1994 Mar; 269(11):8582-9. PubMed ID: 7510691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcineurin activates transcription from the GM-CSF promoter in synergy with either protein kinase C or NF-kappa B/AP-1 in T cells.
    Tsuboi A; Muramatsu M; Tsutsumi A; Arai K; Arai N
    Biochem Biophys Res Commun; 1994 Mar; 199(2):1064-72. PubMed ID: 8135780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation of interleukin-2 gene expression by CD69-generated signals.
    D'Ambrosio D; Trotta R; Vacca A; Frati L; Santoni A; Gulino A; Testi R
    Eur J Immunol; 1993 Nov; 23(11):2993-7. PubMed ID: 8223876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple signals are required for function of the human granulocyte-macrophage colony-stimulating factor gene promoter in T cells.
    Jenkins F; Cockerill PN; Bohmann D; Shannon MF
    J Immunol; 1995 Aug; 155(3):1240-51. PubMed ID: 7636192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The weak, fine-tuned binding of ubiquitous transcription factors to the Il-2 enhancer contributes to its T cell-restricted activity.
    Hentsch B; Mouzaki A; Pfeuffer I; Rungger D; Serfling E
    Nucleic Acids Res; 1992 Jun; 20(11):2657-65. PubMed ID: 1614851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular regulation of the human IL-3 gene: inducible T cell-restricted expression requires intact AP-1 and Elf-1 nuclear protein binding sites.
    Gottschalk LR; Giannola DM; Emerson SG
    J Exp Med; 1993 Nov; 178(5):1681-92. PubMed ID: 8228815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the granulocyte-macrophage colony-stimulating factor promoter in T cells requires cooperative binding of Elf-1 and AP-1 transcription factors.
    Wang CY; Bassuk AG; Boise LH; Thompson CB; Bravo R; Leiden JM
    Mol Cell Biol; 1994 Feb; 14(2):1153-9. PubMed ID: 8289796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell functional regions of the human IL-3 proximal promoter.
    Ryan GR; Vadas MA; Shannon MF
    Mol Reprod Dev; 1994 Oct; 39(2):200-7. PubMed ID: 7826623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.
    Briegel K; Hentsch B; Pfeuffer I; Serfling E
    Nucleic Acids Res; 1991 Nov; 19(21):5929-36. PubMed ID: 1945879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunosuppressant FK-506 specifically inhibits mitogen-induced activation of the interleukin-2 promoter and the isolated enhancer elements NFIL-2A and NF-AT1.
    Banerji SS; Parsons JN; Tocci MJ
    Mol Cell Biol; 1991 Aug; 11(8):4074-87. PubMed ID: 1712901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcineurin potentiates activation of the granulocyte-macrophage colony-stimulating factor gene in T cells: involvement of the conserved lymphokine element 0.
    Tsuboi A; Masuda ES; Naito Y; Tokumitsu H; Arai K; Arai N
    Mol Biol Cell; 1994 Jan; 5(1):119-28. PubMed ID: 8186461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The AP-1 site at -150 bp, but not the NF-kappa B site, is likely to represent the major target of protein kinase C in the interleukin 2 promoter.
    Jain J; Valge-Archer VE; Sinskey AJ; Rao A
    J Exp Med; 1992 Mar; 175(3):853-62. PubMed ID: 1740667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo anergized CD4+ T cells express perturbed AP-1 and NF-kappa B transcription factors.
    Sundstedt A; Sigvardsson M; Leanderson T; Hedlund G; Kalland T; Dohlsten M
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):979-84. PubMed ID: 8577772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of nuclear factor-kappa B and activator protein-1 activities after stimulation of T cells via glycosylphosphatidylinositol-anchored Ly-6A/E.
    Ivanov V; Fleming TJ; Malek TR
    J Immunol; 1994 Sep; 153(6):2394-406. PubMed ID: 7915738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive and negative regulation of the composite octamer motif of the interleukin 2 enhancer by AP-1, Oct-2, and retinoic acid receptor.
    de Grazia U; Felli MP; Vacca A; Farina AR; Maroder M; Cappabianca L; Meco D; Farina M; Screpanti I; Frati L; Gulino A
    J Exp Med; 1994 Oct; 180(4):1485-97. PubMed ID: 7931079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 synergy with phosphoinositide pathway agonists for induction of interleukin-2 gene expression: molecular basis of costimulation.
    Novak TJ; Chen D; Rothenberg EV
    Mol Cell Biol; 1990 Dec; 10(12):6325-34. PubMed ID: 2174106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 Tat inhibits IL-2 gene transcription through qualitative and quantitative alterations of the cooperative Rel/AP1 complex bound to the CD28RE/AP1 composite element of the IL-2 promoter.
    González E; Punzón C; González M; Fresno M
    J Immunol; 2001 Apr; 166(7):4560-9. PubMed ID: 11254713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ETS1, NFkappaB and AP1 synergistically transactivate the human GM-CSF promoter.
    Thomas RS; Tymms MJ; McKinlay LH; Shannon MF; Seth A; Kola I
    Oncogene; 1997 Jun; 14(23):2845-55. PubMed ID: 9190901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha, interleukin 1, and phorbol myristate acetate are independent activators of NF-kappa B which differentially activate T cells.
    Krasnow SW; Zhang LQ; Leung KY; Osborn L; Kunkel S; Nabel GJ
    Cytokine; 1991 Sep; 3(5):372-9. PubMed ID: 1751774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.